Trevi Therapeutics, Inc. (TRVI) vs Vir Biotechnology, Inc. (VIR)
- Trevi Therapeutics, Inc. TRVI 11.87 −1.98%
- Vir Biotechnology, Inc. VIR 9.96 −4.87%
Trevi Therapeutics, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Trevi Therapeutics, Inc. and Vir Biotechnology, Inc. are of similar size ($1.8B and $1.7B). Trevi Therapeutics, Inc. has the higher net margin (0.00% vs −83.0%) and the lower return on invested capital (−1,412.1% vs −39.1%). Across the 13 metrics below, Trevi Therapeutics, Inc. leads on 9 and Vir Biotechnology, Inc. on 4.
Valuation
Profitability
| Metric | TRVI | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (92.40%) | 0.00% |
| Net margin | 0.00% | (83.00%) | 0.00% |
| Free cash flow margin | 0.00% | (67.17%) | 0.00% |
| Return on equity | (19.66%) | (26.08%) | (56.36%) |
| Return on assets | (18.97%) | (20.91%) | (48.04%) |
| Return on invested capital | (1,412.11%) | (39.10%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack